WORX - SCWorx Corp.
After hours:
| Previous Close | 0.2784 |
| Open | 0.2844 |
| Bid | 0.2701 x 1400 |
| Ask | 0.2970 x 1100 |
| Day's Range | 0.2701 - 0.2844 |
| 52 Week Range | 0.2600 - 1.0900 |
| Volume | |
| Avg. Volume | 37,270 |
| Market Cap | 3.521M |
| Beta (5Y Monthly) | 2.30 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1300 |
| Earnings Date | Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireNew York Hospital Selects SCWorx for Data Management and Workday Implementation Assistance
New York, NY, April 25, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has signed another new healthcare provider for its SaaS data management service offering and Workday implementation assistance. This new hospital customer, headquartered in New York, is a non-profit academic healthcare provider with over 400 beds under management. In addition to the company’s data management service offering the hospital will utilize SCWorx expertise and application functionality
- GlobeNewswire
SCWorx Announces New Hospital Customer
New York, NY, Jan. 30, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has signed a new healthcare provider for the utilization of its recently launched SaaS service offering. SCWorx’s new product offering continues to enable hospitals of all sizes to quickly and easily benefit from the SCWorx data platform. This new customer, headquartered in Texas, is a private healthcare provider with nearly 8,000 beds under management. SCWorx offers a technically advanced solutio
- GlobeNewswire
SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
December 13, 2022 New York, Dec. 13, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (Nasdaq: WORX) ("SCWorx" or the "Company"), a software-as-a-service company focused on data management for healthcare providers received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company now has until
- GlobeNewswire
SCWorx Announces New Product and the Signing of Two New Hospital Customers
New York, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has launched a new product offering for healthcare providers along with the signing of two new mid-Atlantic hospitals for the product. The new product offering enables hospitals of all sizes to quickly and easily benefit from the SCWorx data platform. SCWorx offers a technically advanced solution which has proven to be beneficial to large hospitals with challenging technical and data management i
- GlobeNewswire
SCWorx Announces the Renewal and Significant Expansion of an Existing Contract with a New England Hospital
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (NASDAQ: WORX) today announced the renewal and expansion of a data service agreement with an existing 500+ bed hospital in New England. The healthcare provider was previously under a 1 year, $125,000 agreement with SCWorx for data management services. The new agreement is for 4 years, $200,000 per year. The agreement includes currently provided services as well as extended services which are enabled through the normalization, enrichment and
- GlobeNewswire
SCWorx Extends Agreement with one of the Top Five Integrated Delivery Networks in the U.S.
NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (NASDAQ: WORX) today announced the signing of a 2-year service agreement extension with a highly respected Integrated Delivery Network (“IDN”) ranked in the Top 5 largest IDN’s in the United States (Definitive Healthcare List: Top 25 IDN by Net Patient Revenue). An integrated delivery network (“IDN”) is an organization with a group of allied healthcare providers along with local healthcare facilities. This current customer was previously co
- GlobeNewswire
SCWorx Announces Final Approval of Previously Disclosed Securities Class Action and Derivative Action Lawsuits
New York, NY, July 06, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp. (Nasdaq: WORX) today announced that it has received final court approval to settle both the securities class action and derivative action lawsuits which were commenced in 2020. The class action was consolidated under the caption Yannes v. SCWorx Corp. (1:20-cv-03349). The settlement resolves all claims asserted against SCWorx and the other named defendant without any admission of liability or wrongdoing by the Company or any defendant.
- GlobeNewswire
SCWorx Announces Common Stock Purchase Agreement with Institutional Investor
New York, NY, July 05, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp., a Delaware corporation (the “Company”), announced that it has entered into a common stock purchase agreement (the “Purchase Agreement”) with an institutional investor (the “Institutional Investor” or “Investor”). Under the terms and subject to the conditions of the Purchase Agreement, SCWorx will have the right, but not the obligation, to issue and sell to the Investor up to $5 million of SCWorx common stock from time-to-time over the
- GlobeNewswire
SCWorx Completes Settlement of Previously Disclosed SEC Matter
New York, NY, June 06, 2022 (GLOBE NEWSWIRE) -- SCWorx Corp (Nasdaq: WORX) today announced that the Company has received final court approval for a settlement with the Securities and Exchange Commission (“SEC”), to resolve the SEC matter arising out of the Company’s April 13, 2020 press release and the events thereafter (first disclosed in the Company’s March 31, 2020 10-Q). Without admitting or denying the allegations, SCWorx has agreed to a settlement, which has received final court approval,